Anemia and chronic kidney disease are associated with poor outcomes in heart failure patients

BMC Nephrology

Volumn 7, Issue , 2006, Pages

  Luthi, Jean Christophe ^a,b,c   Flanders, W Dana ^c   Burnier, Michel ^d   Burnand, Bernard ^a   McClellan, William M ^c,e  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b Health Observatory   (Switzerland)

^c EMORY UNIVERSITY   (United States)

^d LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^e Georgia Medical Care Foundation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; HEMOGLOBIN;

ADOLESCENT; ADULT; AGED; ANEMIA; ARTICLE; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DEMOGRAPHY; DISEASE ASSOCIATION; FEMALE; HEART FAILURE; HOSPITAL READMISSION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOMES RESEARCH; RETROSPECTIVE STUDY; RISK FACTOR; UNIVERSITY HOSPITAL; BLOOD; CHRONIC DISEASE; FORWARD HEART FAILURE; KIDNEY DISEASE; METABOLISM; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOPHYSIOLOGY; PREVALENCE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANEMIA; CARDIAC OUTPUT, LOW; CHRONIC DISEASE; COHORT STUDIES; CREATININE; FEMALE; HEMOGLOBINS; HOSPITAL MORTALITY; HUMANS; KIDNEY DISEASES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATIENT READMISSION; PREVALENCE; RETROSPECTIVE STUDIES;

EID: 33645275709     PISSN: 14712369     EISSN: 14712369     Source Type: Journal    
DOI: 10.1186/1471-2369-7-3     Document Type: Article

References (33)

1. Williams JF, Bristow MR, Fowler MB, Francis GS, Garson A, Gersh BJ, Hammer DF: Guidelines for the Evaluation and Management of Heart Failure: Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Evaluation and Management of Heart Failure). J Am Coll Cardiol 1995, 26:1376-1398.
2. Remme WJ, Swedberg K, Task Force for the Diagnosis and Treatment of Chronic Heart Failure European Society of Cardiology: Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J 2001, 22:1527-1560.
3. Bailly AS, Periat M Le: coût du petit débit cardiaque: une approche médicométrique. Med et Hyg 1997, 55:1155-9.
4. NIH Consensus Statement: Consensus Development Conference Panel. Morbidity and Mortality of Renal Dialysis. Ann Intern Med 1994, 121:62-67.
5. Rossert JA, Wauters JP: Recommendation for the screening and management of patients with chronic kidney disease. Nephrol Dial Transplant 2002, 17:19-28.
6. US Renal Data System 2001 (USRDS 2001) Annual Data Report. National Institute of Diabetes and Digestive and Kidney Diseases 2001.
7. Cleland JGF, Khand A, Clark AL: The Heart Failure Epidemic: Exactly how big is-it? Eur Heart J 2001, 22:623-626.
8. Petrie MC, Berry C, Stewart S, McMeray JJV: Failing Aging Hearts. Eur Heart J 2001, 22:1978-1990.
9. Miller LW, Nussov ED: Epidemiology of Heart Failure. Cardiologic Clinics 2001, 19:547-555.
10. Erslev AJ, Besarab A: Erythropoietin in Pathogenesis and Treatment of Anemia of Chronic Renal Failure. Kid Intern 1997, 51:622-130.
11. Valderrabano F: Anemia Management in Chronic Kidney Disease Patients: an Overview of Current Clinical Practice. Nephrol Dial Transplant 2002, 17:13-18.
12. Ezekowitz JA, McAlister FA, Armstrong PW: Anemia Is Common in Heart Failure and Is Associated With Poor Outcomes. Insights From a Cohort of 12'065 Patients With New-Onset Heart Failure. Circulation 2003, 107:223-225.
13. Tanner H, Moschovitis G, Kuster GM, Hullin R, Pfiffner D, Hess OM, Mohacsi P: The prevalence of anemia in chronic heart failure. International Journal of Cardiology 2002, 86:115-121.
14. Felker GM, Gattis WA, Leimberger JD, Adams KF, Cuffe MS, Gheorghiade M, O'Connor CM: Usefulness of Anemia as a Predictor of Death and Re-Hospitalization in Patients with Decompensate Heart Failure. Am J Cardiol 2003, 92:625-628.
15. Kosiborod M, Smith GL, Radford MJ, Fooy JM, Krumholz HM: The Prognostic Importance of Anemia in Patients with Heart Failure. Am J Med 2003, 114:112-119.
16. Horwich TB, Fonarow GC, Hamilton MA, MacLellan WR, Borenstein J: Anemia is Associated with Worth Symptoms, Greater in Permanent Functional Capacity and Significant Increase in Mortality in Patients with Advanced Heart Failure. J Am Coll Cardiol 2002, 39:1780-1786.
17. Mozaffarian D, Nye R, Levi WC: Anemia Predicts Mortality in Severe Heart Failure. The Prospective Randomized Am Iodipin Survival Evaluation (PRAISE). J Am Coll Cardiol 2003, 41:1933-1939.
18. Nordyke RJ, Kim JJ, Goldberg GA, Vendiola R, Batra D, McCamish M, Thomasson JW: Impact of Anemia on Hospitalization Time, Charges, and Mortality in Patients with Heart Failure. Value in Health 2004, 7:464-471.
19. Anand I, McMurray JJ, Whitmore J, Warren M, Pham A, McCamish MA, Burton PB: Anemia and its Relationship to Clinical Outcome in Heart Failure. Circulation 2004, 110:149-154.
20. Ryan E, Devlin M, Prendiville TE, Ledwidge M, McDonald K: The prevalence and natural history of anaemia in an optimally treated heart failure population. Br J Cardiol 2004, 11:369-375.
21. Gregory DD, Sarnak MJ, Konstam MA, Pereira B, Salem D: Impact of Chronic Kidney Disease and Anemia on Hospitalization Expense in Patients With Left Ventricular Dysfunction. Am J Cardiol 2003, 92:1300-1305.
22. Al-Ahmad A, Rand WM, Manjunath G, Konstam MA, Salem DN, Levey AS, Sarnak MJ: Reduced Kidney Function and Anemia as Risk Factors for Mortality in Patients with Left Ventricular Dysfunction. J Am Coll Cardiol 2001, 38:955-962.
23. McClellan WM, Flanders WD, Langston RD, Jurkovitz EC, Presley R: Anemia in Renal Insufficiency are Independent in Risk Factors for Death among Patients with Congestive Heart Failure admitted to Community Hospitals: A Population-based Study. J Am Soc Nephrol 2002, 13:1928-1936.
24. Deyo RA, Cherkin DC, Ciol MA: Adapting a clinical comorbity index for use with ICD-9 CM administrative databases. J Clin Epidemiol 1992, 45:613-619.
25. Herzog CA, Li S, Collins AJ: The impact of congestive heart failure (CHF), chronic kidney disease (CKD), and anemia on survival in the Medicare population. Circulation 2002, 106(suppl):471-2.
26. Silverberg DS, Wexler D, Blum M, Keren G, Sheps D, Leibovitch E, Brosh D, Laniado S, Schwartz D, Yachnin T, Shapira I, Gavish D, Baruch R, Koifman B, Kaplan C, Steinbruch S, Iaina A: The Use of Subcutaneous Erythropoietin and Intravenous Iron for the Treatment of Anemia of Severe, Resistant Congestive Heart Failure Improved Cardiac and Renal Function and Functional Cardiac Class, And Markedly Reduces Hospitalization. J Am Coll Cardiol 2000, 35:1737-1744.
27. National Kidney Foundation K/DOQI clinical practice guidelines for anemia of chronic kidney disease: update 2000. Am J Kidney Dis 2001, 37(suppl 1):S182-S238.
28. Dries DL, Exner DV, Domanski MJ, Greenberg B, Stevenson LW: The Prognostic Implications of Renal Insufficiency in Asymptomatic Patients with Left Ventricular Systolic Dysfunction. J Am Coll Cardiol 2000, 35:681-689.
29. Hillege HL, Girbes AR, de Kam PJ, Boomsma F, de Zeeuw D, Charlesworth A, Hampton JR, van Veldhuisen DJ: Renal Function, Neuro-hormonal Activation, and Survival in Patients with Chronic Heart Failure. Circulation 2000, 102:203-210.
30. Crommie N, Lee C, Struthers AD: Anemia in Chronic Heart Failure: What is its frequency in the UK and its underlining causes? Heart 2002, 87:377-378.
31. Coletta AP, Niktin N, Clarc AL, Cleland IJGF: Clinical Trials Updates from the American Heart Association Meeting: PROSPER, DIAL, Home Care Monitoring Trials, Immuno-Modulation Therapy, COMPANION and Anemia in Heart Failure. European Journal of Heart Failure 2003, 5:95-99.
32. Silverberg DS, Wexler D, Blum M, Tchebiner J, Sheps D, Keren G, Schwartz D, Baruch R, Yachnin T, Shaked M, Zubkov A, Steinbruch S, Iaina A: The Correction of Anemia in Severe Resistant Heart Failure with Erythropoietin in Intravenous Iron Prevents the Progression of Both the Heart and the Renal Failure and Markedly Reduces Hospitalization. Clinical Nephrology 2002, 58(suppl 1):S37-S45.
33. European Best Practice Guidelines for the Management of Anemia in Patients with chronic Renal Failure. Nephrol Dial Transplant 1999, 14(suppl 5):1-50.